Venture Capital
Andrea Alms Video: Money In Motion 25 - The Virus Filtration Market
October 2022 - Venture Capital
TRANSCRIPT:
Hello. My name is Andrea Alms and I am technology investor and financial manager. And this is your money in motion. I was asked about norovirus this year. More than 220 people were infected in the Grand Canyon National Park. Largest norovirus outbreak. In response, the CDC recommended regular disinfection of drinkable water spigots, promotion of proper handwashing and public restroom hospitals. Air filtration is also recommended. Hmm. So what is the virus filtration market? Between 2022 and 2026, the market size is expected to grow to 1.5 billion U.S. dollars, accelerating at a compound average growth rate of 13%. However, this global virus filtration market report cites that the expansion will be from 4.1 billion in 2021 to 7.8 billion in 2027 at a compound average growth rate of 11%. The market is being driven by increasing demand for biopharma, physical drugs and the rising prevalence of chronic diseases. In particular, it is the single use of viral filtration products for manufacturing meds since the virus filtration market is moderately competitive and consists of several major players. With the rising cost of R&D. There are fewer or smaller biopharma entrants. Some of the major players are Asahi, Kansai, Charles River Laboratories, General Electric Company, Dana Herr and Merck Kgaa, among others. Thank you. This is your money. Your money in motion.